Literature DB >> 22807482

X-ray crystal structure of the streptococcal specific phage lysin PlyC.

Sheena McGowan1, Ashley M Buckle, Michael S Mitchell, James T Hoopes, D Travis Gallagher, Ryan D Heselpoth, Yang Shen, Cyril F Reboul, Ruby H P Law, Vincent A Fischetti, James C Whisstock, Daniel C Nelson.   

Abstract

Bacteriophages deploy lysins that degrade the bacterial cell wall and facilitate virus egress from the host. When applied exogenously, these enzymes destroy susceptible microbes and, accordingly, have potential as therapeutic agents. The most potent lysin identified to date is PlyC, an enzyme assembled from two components (PlyCA and PlyCB) that is specific for streptococcal species. Here the structure of the PlyC holoenzyme reveals that a single PlyCA moiety is tethered to a ring-shaped assembly of eight PlyCB molecules. Structure-guided mutagenesis reveals that the bacterial cell wall binding is achieved through a cleft on PlyCB. Unexpectedly, our structural data reveal that PlyCA contains a glycoside hydrolase domain in addition to the previously recognized cysteine, histidine-dependent amidohydrolases/peptidases catalytic domain. The presence of eight cell wall-binding domains together with two catalytic domains may explain the extraordinary potency of the PlyC holoenyzme toward target bacteria.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22807482      PMCID: PMC3412044          DOI: 10.1073/pnas.1208424109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines.

Authors:  S L Snyder; P Z Sobocinski
Journal:  Anal Biochem       Date:  1975-03       Impact factor: 3.365

2.  Protein disorder: conformational distribution of the flexible linker in a chimeric double cellulase.

Authors:  Ingemar von Ossowski; Julian T Eaton; Mirjam Czjzek; Stephen J Perkins; Torben P Frandsen; Martin Schülein; Pierre Panine; Bernard Henrissat; Veronique Receveur-Bréchot
Journal:  Biophys J       Date:  2005-01-14       Impact factor: 4.033

3.  Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus.

Authors:  Peter Sass; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

4.  LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae.

Authors:  David G Pritchard; Shengli Dong; Marion C Kirk; Robert T Cartee; John R Baker
Journal:  Appl Environ Microbiol       Date:  2007-09-28       Impact factor: 4.792

5.  Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci.

Authors:  Marianne Horgan; Gary O'Flynn; Jennifer Garry; Jakki Cooney; Aidan Coffey; Gerald F Fitzgerald; R Paul Ross; Olivia McAuliffe
Journal:  Appl Environ Microbiol       Date:  2008-12-01       Impact factor: 4.792

6.  Federated repositories of X-ray diffraction images.

Authors:  Steve Androulakis; Jason Schmidberger; Mark A Bate; Ross DeGori; Anthony Beitz; Cyrus Keong; Bob Cameron; Sheena McGowan; Corrine J Porter; Andrew Harrison; Jane Hunter; Jennifer L Martin; Bostjan Kobe; Renwick C J Dobson; Michael W Parker; James C Whisstock; Joan Gray; Andrew Treloar; David Groenewegen; Neil Dickson; Ashley M Buckle
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-06-18

7.  PlyC: a multimeric bacteriophage lysin.

Authors:  Daniel Nelson; Raymond Schuch; Peter Chahales; Shiwei Zhu; Vincent A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

8.  Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin.

Authors:  David M Donovan; Michelle Lardeo; Juli Foster-Frey
Journal:  FEMS Microbiol Lett       Date:  2006-10-19       Impact factor: 2.742

9.  Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme.

Authors:  C Croux; C Ronda; R López; J L García
Journal:  Mol Microbiol       Date:  1993-09       Impact factor: 3.501

10.  Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity.

Authors:  Mathias Schmelcher; Vincent S Tchang; Martin J Loessner
Journal:  Microb Biotechnol       Date:  2011-04-27       Impact factor: 5.813

View more
  43 in total

Review 1.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

2.  Molecular dissection of phage lysin PlySs2: integrity of the catalytic and cell wall binding domains is essential for its broad lytic activity.

Authors:  Yanling Huang; Hang Yang; Junping Yu; Hongping Wei
Journal:  Virol Sin       Date:  2015-02-04       Impact factor: 4.327

3.  A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.

Authors:  Rolf Lood; Assaf Raz; Henrik Molina; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

4.  Bacteriophage φEf11 ORF28 Endolysin, a Multifunctional Lytic Enzyme with Properties Distinct from All Other Identified Enterococcus faecalis Phage Endolysins.

Authors:  Hongming Zhang; Roy H Stevens; Bettina A Buttaro; Derrick E Fouts; Salar Sanjari; Bradley S Evans
Journal:  Appl Environ Microbiol       Date:  2019-06-17       Impact factor: 4.792

5.  Structures of a bifunctional cell wall hydrolase CwlT containing a novel bacterial lysozyme and an NlpC/P60 DL-endopeptidase.

Authors:  Qingping Xu; Hsiu-Ju Chiu; Carol L Farr; Lukasz Jaroszewski; Mark W Knuth; Mitchell D Miller; Scott A Lesley; Adam Godzik; Marc-André Elsliger; Ashley M Deacon; Ian A Wilson
Journal:  J Mol Biol       Date:  2013-09-16       Impact factor: 5.469

6.  ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain.

Authors:  Hang Yang; Yujing Gong; Huaidong Zhang; Irina Etobayeva; Paulina Miernikiewicz; Dehua Luo; Xiaohong Li; Xiaoxu Zhang; Krystyna Dąbrowska; Daniel C Nelson; Jin He; Hongping Wei
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

7.  A Choline-Recognizing Monomeric Lysin, ClyJ-3m, Shows Elevated Activity against Streptococcus pneumoniae.

Authors:  Dehua Luo; Li Huang; Vijay Singh Gondil; Wanli Zhou; Wan Yang; Minghui Jia; Shencai Hu; Jin He; Hang Yang; Hongping Wei
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

Review 8.  Antimicrobial bacteriophage-derived proteins and therapeutic applications.

Authors:  Dwayne R Roach; David M Donovan
Journal:  Bacteriophage       Date:  2015-06-23

9.  Architecture of the mycobacterial type VII secretion system.

Authors:  Nikolaos Famelis; Angel Rivera-Calzada; Gianluca Degliesposti; Maria Wingender; Nicole Mietrach; J Mark Skehel; Rafael Fernandez-Leiro; Bettina Böttcher; Andreas Schlosser; Oscar Llorca; Sebastian Geibel
Journal:  Nature       Date:  2019-10-09       Impact factor: 49.962

Review 10.  Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria.

Authors:  Bingqing Yang; Dan Fang; Qingyan Lv; Zhiqiang Wang; Yuan Liu
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.